Opinion: How Postdocs Can Participate

Graduate students and postdoctoral researchers should be taking part in discussions on the future of biomedical research.

Written byJessica Polka
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

FLICKR, RICHARD RUTTERThe US biomedical research landscape is in flux, and a growing number of white papers, recommendations, workshops, and editorials speak to an urgent need for fundamental changes to the systems for distributing funding, evaluating work, and training scientists. However, there’s one key group missing from many of these discussions on how to fix biomedical research: graduate students and postdoctoral researchers. While the perspective and experience of senior scientists is invaluable, it is we junior scientists who will work in the landscape shaped by these decisions. While it’s easy to feel paralyzed by uncertainty, grad students and postdocs need to, as blogger Biochem Belle has put it, “claim our seat at the table or be left behind.”

Here are three ways to do just that:

Educate ourselves

Grad students and postdocs frequently talk about workforce stability, funding structure, and training, but much of this discussion is fueled with only anecdotes and generalities. We should understand the facts about the current state of the biomedical research system and share them to enrich the discussion and empower our colleagues.

Find a positive voice

Although we are directly affected by the ailments of the system, it’s vital for us to practice speaking without bitterness. Maintaining objectivity will make it possible to discuss these issues with people outside of our immediate circles—senior faculty, administrators, and other leaders—without playing into the easily-dismissed stereotype of the disgruntled trainee. Instead, we need to find ways to engage in a positive way. We share a common vision of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies